SCYX logo

SCYNEXIS (SCYX) Company Overview

Profile

Full Name:

SCYNEXIS, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 2, 2014

Indexes:

Not included

Description:

SCYNEXIS, Inc. is a biotechnology company focused on developing innovative treatments for serious infections. Their main product, SCY-078, targets fungal infections. The company aims to improve patient outcomes by providing effective therapies for diseases that are difficult to treat, addressing unmet medical needs in healthcare.

Key Details

Price

$0.99

Annual Revenue

$140.14 M(+2652.72% YoY)

Annual EPS

$1.39(+194.56% YoY)

Annual ROE

175.97%

Beta

1.34

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 31, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 17, 2020

Analyst ratings

Recent major analysts updates

Apr 1, 24 Cantor Fitzgerald
Overweight
Aug 15, 23 Cantor Fitzgerald
Overweight
Apr 3, 23 Ladenburg Thalmann
Buy
Apr 3, 23 Guggenheim
Buy
Mar 1, 23 Guggenheim
Buy
May 13, 22 HC Wainwright & Co.
Buy
Mar 31, 22 HC Wainwright & Co.
Buy
Jun 7, 21 Aegis Capital
Buy
Apr 12, 21 Aegis Capital
Buy
Jan 22, 21 Guggenheim
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for SCYNEXIS?
  • Does SCYNEXIS pay dividends?
  • What sector is SCYNEXIS in?
  • What industry is SCYNEXIS in?
  • What country is SCYNEXIS based in?
  • When did SCYNEXIS go public?
  • Is SCYNEXIS in the S&P 500?
  • Is SCYNEXIS in the NASDAQ 100?
  • Is SCYNEXIS in the Dow Jones?
  • When was SCYNEXIS's last earnings report?
  • When does SCYNEXIS report earnings?
  • Should I buy SCYNEXIS stock now?

What is the ticker symbol for SCYNEXIS?

The ticker symbol for SCYNEXIS is NASDAQ:SCYX

Does SCYNEXIS pay dividends?

No, SCYNEXIS does not pay dividends

What sector is SCYNEXIS in?

SCYNEXIS is in the Healthcare sector

What industry is SCYNEXIS in?

SCYNEXIS is in the Drug Manufacturers - Specialty & Generic industry

What country is SCYNEXIS based in?

SCYNEXIS is headquartered in United States

When did SCYNEXIS go public?

SCYNEXIS's initial public offering (IPO) was on May 2, 2014

Is SCYNEXIS in the S&P 500?

No, SCYNEXIS is not included in the S&P 500 index

Is SCYNEXIS in the NASDAQ 100?

No, SCYNEXIS is not included in the NASDAQ 100 index

Is SCYNEXIS in the Dow Jones?

No, SCYNEXIS is not included in the Dow Jones index

When was SCYNEXIS's last earnings report?

SCYNEXIS's most recent earnings report was on Nov 6, 2024

When does SCYNEXIS report earnings?

The next expected earnings date for SCYNEXIS is Mar 28, 2025

Should I buy SCYNEXIS stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions